Go
All Publishers
Prodigy Press Wire
IssueWire
StatePoint Media
Press Advantage
Investor Brand Network
GlobeNewswire
PR Newswire
Brandpoint
3BL Media
NewsUSA
Send2Press
AccessWire
RestaurantNews.com
NewsDirect
Syndication Cloud
PRUnderground
PR.com
Newsworthy.ai
Evertise Digital
WebWire
iCrowdNewswire
PR Distribution
24-7 Press Release Newswire
Press Services
PRWire360
Law Firm Newswire
Media OutReach
Get Featured
TheNewswire.com
EZ Newswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Unisys Corporation Investors to Inquire About Securities Class Action Investigation – UIS
GlobeNewsWire
Today at 6:39pm UTC
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat
GlobeNewsWire
Today at 5:40pm UTC
TECVAYLI® (teclistamab-cqyv) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma
PR Newswire
Today at 5:33pm UTC
EBM Technologies and OmniPACS Partner to Transform Medical Imaging for Small to Medium Healthcare Providers in the US
PR.com
Today at 5:32pm UTC
C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to...
GlobeNewsWire
Today at 5:30pm UTC
Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin Lymphoma
PR Newswire
Today at 5:30pm UTC
ROSEN, A LEADING LAW FIRM, Encourages Symbotic Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First...
GlobeNewsWire
Today at 5:11pm UTC
Apple Sued for Knowingly Hosting Child Sexual Abuse Material on Its Products, Failing to Protect Survivors
PR Newswire
Today at 5:05pm UTC
Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at...
GlobeNewsWire
Today at 5:00pm UTC
Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical...
GlobeNewsWire
Today at 5:00pm UTC
Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced...
GlobeNewsWire
Today at 5:00pm UTC
TD DEADLINE NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages The Toronto-Dominion Bank Investors to Secure Counsel Before Important...
GlobeNewsWire
Today at 4:52pm UTC
Jeffco Public Schools Benefit from Donation of Intermountain Health Lutheran Hospital Equipment
PRUnderground
Today at 4:51pm UTC
Global Times: People's Daily article says favorable conditions for China's economic development remain unchanged
PR Newswire
Today at 4:50pm UTC
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Dentsply Sirona Inc. Investors to Secure Counsel Before Important Deadline in Securities Class...
GlobeNewsWire
Today at 4:36pm UTC
Powering Canada's Future: Ensuring Access to Affordable, Reliable and Clean Electricity in New Brunswick
PR Newswire
Today at 4:24pm UTC
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) shows 51 percent reduction in risk of progression to active multiple myeloma for...
PR Newswire
Today at 4:21pm UTC
ROSEN, LEADING NATIONAL TRIAL COUNSEL, Encourages Zeta Global Holdings Corp. Investors to Secure Counsel Before Important Deadline in...
GlobeNewsWire
Today at 4:17pm UTC
Rosen Law Firm Encourages IMX Token Purchasers to Inquire About Immutable Securities Class Action Investigation
PR Newswire
Today at 4:17pm UTC
TD INVESTOR NOTICE: The Toronto-Dominion Bank Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
PR Newswire
Today at 4:15pm UTC
<
1
2
3
4
5
6
...
19
20
>
Skip to main content
Nominate
About Us
Subscribe
Events
Commercial Real Estate
Webinars
Enterprise
Viewpoints
Calendar
Directory
Advice
Nominate
The Business Narrative
Sponsored Content
Submit an Event
List Your Business
Login/Join
Search
Search
Enterprise
Viewpoints
Calendar
Directory
Advice
Nominate
The Business Narrative